Dibekacin sulfate
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281645This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O8.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0869I992Z, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-2-deoxy-, sulfate (salt) but more generally known as dibekacin sulfate, which bears US NIH Compound Identifier 162862. European Medicines Agency schedules Dibekacin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01657MIG. Most nations, for tariff and trade purposes, schedule dibekacin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, DIBEKACIN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N.OS(=O)(=O)O.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.